ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,367
Screening encounters
3,897
Diagnostic referrals
744
Outstanding pathways
280

Screening pathway

  1. Screening3,897Encounters
  2. Positive finding1,352Documented findings
  3. Referral744Diagnostic referrals
  4. Follow-up872Diagnostic visits
  5. Outcome464Resolved pathways

Stage totals use different units. Pending pathways: 280. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1908 · EXP-1908Synthetic · Site D

Full participant history through 2026-08-24, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Repeat plan · HPV DNA · Prior HPV positive · Scheduled for 2026-03-22
  4. · Screening · HPV DNA · Repeat · Prior HPV positive
  5. · Screening result · HPV DNA · HPV detected · Adequate
  6. · Diagnostic referral · EXP-1908-T-R
  7. · Contact attempt · Unsuccessful
  8. · Diagnostic booking · Initial booking
  9. · Contact attempt · Reached
  10. · Diagnostic visit · Attended
  11. · Diagnosis · Colposcopy · Biopsy collected
  12. · Diagnosis · Histopathology · No high-grade lesion identified
  13. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-05-19
  14. · Follow-up disposition · Resolved · EXP-1908-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

3367 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0337 · Expanded synthetic participant 0337Site B — Peri-Urban Access Programme
EXP-0338 · Expanded synthetic participant 0338Site C — Rural Outreach Programme
EXP-0341 · Expanded synthetic participant 0341Site C — Rural Outreach Programme
EXP-0342 · Expanded synthetic participant 0342Site D — Community Engagement Programme
EXP-0343 · Expanded synthetic participant 0343Site A — Urban Referral Hub
EXP-0345 · Expanded synthetic participant 0345Site D — Community Engagement Programme
EXP-0347 · Expanded synthetic participant 0347Site C — Rural Outreach Programme
EXP-0348 · Expanded synthetic participant 0348Site E — Resource-Constrained Navigation Programme
EXP-0349 · Expanded synthetic participant 0349Site D — Community Engagement Programme
EXP-0350 · Expanded synthetic participant 0350Site C — Rural Outreach Programme
EXP-0351 · Expanded synthetic participant 0351Site C — Rural Outreach Programme
EXP-0352 · Expanded synthetic participant 0352Site D — Community Engagement Programme
EXP-0353 · Expanded synthetic participant 0353Site B — Peri-Urban Access Programme
EXP-0354 · Expanded synthetic participant 0354Site D — Community Engagement Programme
EXP-0355 · Expanded synthetic participant 0355Site B — Peri-Urban Access Programme
EXP-0356 · Expanded synthetic participant 0356Site B — Peri-Urban Access Programme
EXP-0358 · Expanded synthetic participant 0358Site B — Peri-Urban Access Programme
EXP-0359 · Expanded synthetic participant 0359Site D — Community Engagement Programme
EXP-0360 · Expanded synthetic participant 0360Site E — Resource-Constrained Navigation Programme
EXP-0361 · Expanded synthetic participant 0361Site B — Peri-Urban Access Programme
EXP-0364 · Expanded synthetic participant 0364Site B — Peri-Urban Access Programme
EXP-0365 · Expanded synthetic participant 0365Site A — Urban Referral Hub
EXP-0367 · Expanded synthetic participant 0367Site A — Urban Referral Hub
EXP-0368 · Expanded synthetic participant 0368Site A — Urban Referral Hub
EXP-0369 · Expanded synthetic participant 0369Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1540
HPV DNA
1801
Cytology
556

Navigation activity

Barrier documented
641
Contact attempt
1089
Navigation intervention
274
Diagnostic booking
916
Diagnostic visit
872

Documented barriers

Contact difficulty
213
Transport difficulty
201
Appointment coordination
227

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.